Cureus
September 1, 2023
Javairia Ayyub, Sailaja Nandennagari, Dylan Edelbaum et al.
1 citation
Hallucinogen-persisting perception disorder (HPPD), also known as acute hallucinogen-induced psychosis or informally known as "flashbacks," is an unusual condition experienced by patients due to the use of different hallucinogenic substances. Hallucinogen-persisting perception disorder causes many symptoms, predominantly persistent visual perception distortion instead of intermittent...
Behavioural Brain Research
August 24, 2023
Daniel T Sangiamo, Michael J Weingarten, Nnamdi G Nelson et al.
Combined use of cannabis and alcohol is common in adolescents. However, the extent to which such polydrug exposure affects the brain and behaviors remains under-investigated in preclinical studies. This study tested the hypothesis that combined exposure of Δ-9-tetrahydrocannabinol (THC), the main psychoactive constituent of cannabis, and alcohol will have additive effects on cognitive...
medRxiv
August 20, 2023
Steven Tate, Nicolas Garel, Kristin Nash et al.
1 citation
preprint
Abstract Objectives Hallucinogens encompass a diverse range of compounds with increasing scientific and public interest. Risks associated with hallucinogen use are poorly understood. This study aims to evaluate the trends in hallucinogen-related emergency department visits and hospitalizations in California from 2016 to 2021, as compared to alcohol and cannabis visits and hospitalizations...
Disparidades Revista de Antropología
August 18, 2023
John Harvy Arcia Grajales
2 citations
El presente estudio realiza una lectura histórico - crítica al consumo de sustancias psicoactivas en contextos indígenas. Se hace un recorte de realidad - con autoridades, docentes, estudiantes y cuidadores - acerca de los saberes, relaciones y prácticas situadas en Sipirra sobre sustancias psicoactivas. A través del mapeo colectivo se relatan las acciones comunitarias, aprendizajes...
Journal of the American Psychiatric Nurses Association
August 10, 2023
G. Pearson
The use of psychedelic medications to treat the brain disorders associated with psychiatric illness has re-emerged in recent years as a viable treatment option (Grieco et al., 2022). Historically there is evidence of hallucinogenic use in religious and spiritual rituals dating back to 500 B.C. (Begola & Dowben, 2018). The discovery of LSD (lysergic acid diethylamine-25) in Switzerland in 1943...
Harm Reduction Journal
August 9, 2023
Hagit Bonny-Noach, Barak Shapira, Pinchas Baumol et al.
9 citations
Few studies have analyzed harm reduction behaviors and attitudes among rave party attendees. Since the late 1980s, there has been a large Israeli rave scene, also known as 'Nature Parties'. However, only a few studies have been conducted among nature party attendees and almost all of them are from a qualitative perspective. This study's aim was to fill the gap and conduct quantitative research...
Rehabilitation psychology
August 1, 2023
Aaron P Turner, Karlyn A Edwards, Mark P Jensen et al.
5 citations
To examine the impact of three behavioral interventions for chronic pain on substance use. Participants were 328 Veterans with chronic pain receiving care at one of two Veterans Affairs Medical Centers in the northwest United States. Participants were randomly assigned to one of three 8-week manualized in-person group treatments: (a) hypnosis (HYP), (b) mindfulness meditation (MM), or (c)...
Clinics in geriatric medicine
August 1, 2023
Kabir Nigam, Kimberly A Curseen, Yvan Beaussant
3 citations
Psychological distress at the end of life is a common experience that lacks effective treatments. This is in part due to the multidimensional nature of psychological distress at the end of life, encompassing an interplay between psychosocial and existential distress as well as physical symptom burden. Research shows that psychedelic-assisted therapy is an effective treatment of end of life...
Pharmacology & Therapeutics
August 1, 2023
Ryoichi Fujiwara, Megan Journey, Fatimah Al-Doori et al.
13 citations
Cannabis, cocaine, 3,4-methylenedioxymethamphetamine, and lysergic acid diethylamide are psychoactive substances with a significant increase in consumption during the 21st century due to their popularity in medicinal and recreational use. New psychoactive substances (NPSs) mimic established psychoactive substances. NPSs are known as being natural and safe to consumers; however, they are neither...
Frontiers in Psychiatry
July 11, 2023
Gniewko Więckiewicz, Iga Stokłosa, Maciej Stokłosa et al.
2 citations
Introduction Attention-deficit/hyperactivity disorder (ADHD) was originally treated as a neurodevelopmental disorder that occurs mainly in children and tends to diminish or disappear with age, but we now know that symptoms persist into adulthood in over 50% of ADHD patients. Undiagnosed individuals often turn to psychoactive substance to minimize the negative aspects of functioning and improve...